These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27827357)

  • 1. Platelet Integrin αIIbβ3 Inhibitor Rescues Progression of Apoptosis in Human Platelets.
    Zhu J; Wang Q; Nie Y; Yan R; Dai K; Zhou B
    Med Sci Monit; 2016 Nov; 22():4261-4270. PubMed ID: 27827357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GPIIbIIIa antagonist drugs eptifibatide and tirofiban do not induce activation of apoptosis executioner caspase-3 in resting platelets but inhibit caspase-3 activation in platelets stimulated with thrombin or calcium ionophore A23187.
    Leytin V; Mutlu A; Mykhaylov S; Allen DJ; Gyulkhandanyan AV; Freedman J
    Haematologica; 2009 Dec; 94(12):1783-4. PubMed ID: 19996122
    [No Abstract]   [Full Text] [Related]  

  • 3. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation.
    Aguiar Bucsai M; Idel C; Wollenberg B; Mannhalter C; Verschoor A
    Platelets; 2022 Nov; 33(8):1192-1198. PubMed ID: 35701857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tirofiban (Aggrastat) protects platelets and decreases platelet-granulocyte binding in an extracorporeal circulation model.
    Straub A; Azevedo R; Beierlein W; Wendel HP; Dietz K; Ziemer G
    Thorac Cardiovasc Surg; 2006 Apr; 54(3):162-7. PubMed ID: 16639676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation.
    Jones ML; Harper MT; Aitken EW; Williams CM; Poole AW
    J Thromb Haemost; 2010 Mar; 8(3):567-76. PubMed ID: 20002543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba.
    Pontiggia L; Steiner B; Ulrichts H; Deckmyn H; Forestier M; Beer JH
    Thromb Haemost; 2006 Dec; 96(6):774-80. PubMed ID: 17139372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Antimalarial Tafenoquine on Blood Platelet Activity and Survival.
    Cao H; Bissinger R; Umbach AT; Al Mamun Bhuyan A; Lang F; Gawaz M
    Cell Physiol Biochem; 2017; 41(1):369-380. PubMed ID: 28214869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Ca2+ Activated Cl- Channel Ano6 in Platelet Activation and Apoptosis.
    Liu G; Liu G; Chen H; Borst O; Gawaz M; Vortkamp A; Schreiber R; Kunzelmann K; Lang F
    Cell Physiol Biochem; 2015; 37(5):1934-44. PubMed ID: 26584292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Bexarotene on Platelet Activation and Apoptosis.
    Cao H; Bissinger R; Umbach AT; Gawaz M; Lang F
    Cell Physiol Biochem; 2017; 42(2):838-847. PubMed ID: 28641286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory Effect of Afatinib on Platelet Activation and Apoptosis.
    Cao H; Bhuyan AAM; Umbach AT; Bissinger R; Gawaz M; Lang F
    Cell Physiol Biochem; 2017; 43(6):2264-2276. PubMed ID: 29073606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
    Ito H; Miyakoda G; Mori T
    Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM; Buckland RJ; Holgate CE; Storey RF
    Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro.
    Hamilton SF; Miller MW; Thompson CA; Dale GL
    J Lab Clin Med; 2004 May; 143(5):320-6. PubMed ID: 15122176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
    Serebruany V; Malinin A; Pokov A; Arora U; Atar D; Angiolillo D
    Thromb Res; 2007; 119(2):175-81. PubMed ID: 16546241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophilin A is an important mediator of platelet function by regulating integrin αIIbβ3 bidirectional signalling.
    Wang L; Soe NN; Sowden M; Xu Y; Modjeski K; Baskaran P; Kim Y; Smolock EM; Morrell CN; Berk BC
    Thromb Haemost; 2014 May; 111(5):873-82. PubMed ID: 24429998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood.
    Furman MI; Krueger LA; Frelinger AL; Barnard MR; Mascelli MA; Nakada MT; Michelson AD
    Thromb Haemost; 2000 Sep; 84(3):492-8. PubMed ID: 11019977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet glycoprotein IIb/IIIa blockade with tirofiban: effect on aggregation caused by P256, an antibody to human IIb/IIIa receptors.
    Fisher I; Robinson P; Ritter JM
    Br J Clin Pharmacol; 1999 Aug; 48(2):197-9. PubMed ID: 10417496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared -triggered release of tirofiban from nanocarriers for the inhibition of platelet integrin αIIbβ3 to decrease early-stage neointima formation.
    Zhao Z; Qiu P; Lu H; Yin M; Liu X; Li F; Liu K; Li D; Lu X; Li B
    Nanoscale; 2020 Feb; 12(7):4676-4685. PubMed ID: 32048702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human thrombocytes are able to induce a myocardial dysfunction in the ischemic and reperfused guinea pig heart mediated by free radicals-role of the GPIIb/IIIa-blocker tirofiban.
    Seligmann C; Simsek Y; Schimmer M; Leitsch T; Bock A; Schultheiss HP
    Life Sci; 2002 Sep; 71(19):2319-29. PubMed ID: 12215379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.